ASPIRIN: Neurodevelopmental Follow-up Trial
Public ClinicalTrials.gov record NCT04888377. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Aspirin Supplementation for Pregnancy Indicated Risk Reduction in Nulliparas (ASPIRIN): Neurodevelopmental Follow-up Trial
Study identification
- NCT ID
- NCT04888377
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- NICHD Global Network for Women's and Children's Health
- Network
- Enrollment
- 666 participants
Conditions and interventions
Conditions
Interventions
- Aspirin Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 33 Months to 39 Months
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2021
- Primary completion
- Jun 14, 2022
- Completion
- Jun 14, 2022
- Last update posted
- Oct 20, 2024
2021 – 2022
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama, Birmingham | Birmingham | Alabama | 35233 | — |
| University of Colorado Health Sciences Center | Denver | Colorado | 80208 | — |
| Christiana Care | Newark | Delaware | 19718 | — |
| Boston University | Boston | Massachusetts | 02115 | — |
| Columbia University | New York | New York | 10032 | — |
| University of North Carolina School of Medicine | Chapel Hill | North Carolina | 27599 | — |
| RTI International | Research Triangle Park | North Carolina | 27709 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04888377, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 20, 2024 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04888377 live on ClinicalTrials.gov.